Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Clinical trial NCT01994590 · TERMINATED
Trial details
- NCT number
- NCT01994590
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-19
- Primary completion
- 2017-06-05
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.